Evidence map›Paper›PMID 36134146›Full record

ArticleNanoscale advances2021

Three-color plasmon-mediated reduction of diazonium salts over metasurfaces.

Denis A B Therien, Danielle M McRae, Claire Mangeney, Nordin Félidj, François Lagugné-Labarthet

Abstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Denis A B TherienDepartment of Chemistry, University of Western Ontario 1151 Richmond Street London ON N6A 5B7 Canada flagugne@uwo.ca.
Danielle M McRaeDepartment of Chemistry, University of Western Ontario 1151 Richmond Street London ON N6A 5B7 Canada flagugne@uwo.ca.
Claire MangeneyUniversité de Paris, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, LCBPT, UMR 8601 CNRS 45 rue des Saints Péres F-75006 Paris France.ORCID https://orcid.org/0000-0002-9817-3262
Nordin FélidjUniversité de Paris, ITODYS, UMR 7086 CNRS 15 rue J.-A. de Baïf F-75013 Paris France.ORCID https://orcid.org/0000-0002-3243-2671
François Lagugné-LabarthetDepartment of Chemistry, University of Western Ontario 1151 Richmond Street London ON N6A 5B7 Canada flagugne@uwo.ca.ORCID https://orcid.org/0000-0001-9882-9367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface plasmon-mediated chemical reactions are of great interest for a variety of applications ranging from micro- and nanoscale device fabrication to chemical reactions of societal interest for hydrogen production or carbon reduction. In this work, a crosshair-like nanostructure is investigated due to its ability to induce local enhancement of the local electromagnetic field at three distinct wavelengths corresponding to three plasmon resonances. The structures are irradiated in the presence of a solution containing diazonium salts at wavelengths that match the resonance positions at 532 nm, 632.8 nm, and 800 nm. The resulting grafting shows polarization and wavelength-dependent growth patterns at the nanoscale. The plasmon-mediated reactions over arrays of the crosshair structures are further investigated using scanning electron microscopy and supported by finite domain time domain modelling revealing wavelength and polarization specific reactions. Such an approach enables nanoscale molecular printing using light source opening multiplexing applications where different analytes can be grafted under distinct opto-geometric conditions.

Identifiers

PMID36134146
PMCPMC9417294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.